Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference
Rhea-AI Summary
Clover Health (Nasdaq: CLOV) said CFO Peter Kuipers will present at the Leerink 2026 Global Healthcare Conference on March 10, 2026 at 9:20 a.m. ET.
A live webcast and replay of the presentation and Q&A will be available on Clover Health's investor relations website at https://investors.cloverhealth.com/.
Positive
- None.
Negative
- None.
News Market Reaction – CLOV
In the Feb 18 session, CLOV gained 2.45%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 29 | Earnings timing update | Neutral | -1.3% | Announced date and webcast details for Q4 and full-year 2025 results. |
| Jan 14 | Membership and outlook | Positive | +10.6% | Reported 53% Medicare Advantage growth to 153,000 members and 2026 GAAP profitability goal. |
| Jan 12 | Clinical impact update | Positive | +1.5% | Highlighted AI-enabled clinical platform outcomes and top nationwide HEDIS score for PPO plan. |
| Dec 16 | Conference participation | Neutral | +0.8% | Announced CEO presentation at 2026 J.P. Morgan Healthcare Conference with webcast access. |
| Nov 17 | Conference participation | Neutral | +0.0% | CFO participation in 2025 Citi Global Healthcare Conference with webcast and replay. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Operational and membership growth updates have previously coincided with positive price reactions, while conference participation and scheduling news have seen minimal impact.
Over the last few months, Clover Health has highlighted growth and visibility milestones. On Jan 14, 2026, it reported a 53% year-over-year Medicare Advantage membership increase to 153,000 members and flagged an expectation of first-ever full-year GAAP net income profitability in 2026, which saw a 10.63% price gain. Prior conference participation announcements on Dec 16, 2025 and Nov 17, 2025 produced minimal moves (≤0.76%), similar in nature to today’s Leerink conference notice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Leerink 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 9:20 a.m. Eastern Time.
A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at https://investors.cloverhealth.com/.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and in Underserved Populations as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
